For the Inventor, By the Inventor

Enter assignee name

Dreieich, Germany

Biotest Pharma Gmbh

USPTO Granted Patents = 23

% Expired Patents = 4.3

CIPO Patents = 1

Forward Citations = 523

Loading Chart...

Loading Chart...

28 inventors (with patents filed for the assignee):

Wolfgang Moller (11 out of 12 patents)

Wolfgang Stephan (10 out of 20 patents)

Herbert Dichtelmuller (7 out of 7 patents)

4. Norbert Kothe (7 out of 9 patents)

5. Dieter Rudnick (6 out of 13 patents)

6. Michael Kloft (5 out of 5 patents)

7. Detlef Piechaczek (5 out of 5 patents)

8. Hans Schleussner (3 out of 8 patents)

9. Michael Kraus (3 out of 3 patents)

10. Bertram Eichentopf (3 out of 4 patents)

11. Ronald Kotitschke (2 out of 9 patents)

12. Ulf Bethke (2 out of 2 patents)

13. Detlef Rohm (2 out of 2 patents)

14. Henry Hies (2 out of 2 patents)

15. Roland Beliard (1 out of 14 patents)

23 patents: Sort by Forward Citations

1. 7041798 - Method for the chromatographic fractionation of plasma or serum, preparations, so obtained, and their use (2006-05-09),

2. 5851524 - Human monoclonal anti-rhesus (D) antibodies and cell lines producing same (1998-12-22),

3. 5710132 - Use of bovine colostral milk as a preparation for the protection of the (1998-01-20),

4. 5643759 - Method for preparing bispecific monoclonal antibodies (1997-07-01),

5. 5576040 - Process for the sterile filtration of milk (1996-11-19),

6. 5410025 - Unmodified intravenously administered immunoglobulin preparations (1995-04-25),

7. 5190752 - Intravenously administerable polyclonal immunoglobulin preparation (1993-03-02),

8. 5164487 - Manufacturing intravenous tolerable immunoglobulin-G preparation (1992-11-17),

9. 5147548 - Colostrum filtered sterile (1992-09-15),

10. 5143838 - Method of producing thrombin from factor II using calcium ions for the (1992-09-01),

11. 5099003 - Method of preparing a sterile plasma-protein solution containing (1992-03-24),

12. 5075425 - Process for the preparation of a pharmaceutical which contains IgG, IgA (1991-12-24),

13. 5071961 - Method of enrichment of coagulation factors II, VII, IX and X (1991-12-10),

14. 5061789 - Method of isolating blood-clotting factor IX (1991-10-29),

15. 5041537 - Method of preparing a high-purity, virus safe, biologically active (1991-08-20),

Biotest Pharma GmbH is a biopharmaceutical company specializing in the development and production of innovative drugs for the treatment of immune system disorders and infectious diseases. With a focus on plasma proteins and monoclonal antibodies, Biotest Pharma is committed to improving the lives of patients worldwide through cutting-edge research and development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

23 Patents

#3 in Dreieich

#1,975 in Germany

#27,581 in the World

Dreieich, Germany

Biotest Pharma Gmbh

Forward Citations = 523

28 inventors:

Wolfgang Moller (11 out of 12 patents)

Wolfgang Stephan (10 out of 20 patents)

Herbert Dichtelmuller (7 out of 7 patents)

4. Norbert Kothe (7 out of 9 patents)

5. Dieter Rudnick (6 out of 13 patents)

Please report any incorrect information to [email protected]

Loading…